BIOZINK

This brand name is authorized in Nigeria.

Active ingredients

The drug BIOZINK contains one active pharmaceutical ingredient (API):

1
UNII 89DS0H96TB - ZINC SULFATE, UNSPECIFIED FORM
 

Zinc sulfate is a source of zinc which is an essential trace element and involved in a number of body enzyme systems. Severe deficiency causes skin lesion, alopecia, diarrhoea, increased susceptibility to infections and failure to thrive in children.

 
Read more about Zinc sulfate

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A11-100525 Tablet BIOZINK TABLET TAB 20 mg 10 X 10 2 NF-PP-209162 BIOZINK TABLET ZINC SULPHATE Zinc Sulphate......20mg Excipient Drugs BLOOD AND BLOOD FORMING ORGANS Nigerian Products 1010 POM 1 9/13/2022 BIORAJ PHARMACEUTICALS LIMITED, 405, KAIAMA ROAD, IIORIN KWARA STATE 8038099594 biorajpharmaceuticalltd@gmail.com BIORAJ PHARMACEUTICAL LTD, P. O. Box 791 Ilorin, Kwara State, Nigeria 06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
A12CB01 Zinc sulfate A Alimentary tract and metabolism → A12 Mineral supplements → A12C Other mineral supplements → A12CB Zinc
Discover more medicines within A12CB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A11-100525

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.